(Q44386848)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

0 references

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Jozsef Halasz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

R J Rodgers

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E Mikics

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670316%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neuroscience

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1279-1286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670316%20AND%20SRC:MED&resulttype=core&format=json

In-vitro and in-vivo action of cannabinoids.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

The effects of cannabinoids on the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Dopamine D4 receptor and anxiety: behavioural profiles of clozapine, L-745,870 and L-741,742 in the mouse plus-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Neurobehavioral effects of anandamide and cannabinoid receptor gene expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Behavioral effects of cannabinoid agents in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Functions of cannabinoid receptors in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

A cannabinoid mechanism in relapse to cocaine seeking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Effects of weekly or daily exposure to the elevated plus-maze in male mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

The influence of open arm ledges and maze experience in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

The interplay of learning and anxiety in the elevated plus-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Some critical determinants of the behaviour of rats in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Adverse effects of cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

The use of a plus-maze to measure anxiety in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Molecular and neuronal substrate for the selective attenuation of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

The endogenous cannabinoid system controls extinction of aversive memories

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Involvement of CB1 cannabinoid receptors in emotional behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Input-dependent synaptic targeting of alpha(2)-subunit-containing GABA(A) receptors in synapses of hippocampal pyramidal cells of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Neurobehavioral effects of delta 9-THC and cannabinoid (CB1) receptor gene expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

The endocannabinoid nervous system: unique opportunities for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Stress and emotionality: a multidimensional and genetic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Modulation of transmitter release via presynaptic cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Biphasic effects of anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Anxiogenic stimuli in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02548.X

10.1046/J.1460-9568.2003.02548.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference